Progesterone (P4) maintains uterine quiescence during the majority of pregnancy, whereas diminished progesterone receptor (PR) expression and/or activity (ie, functional P4 withdrawal) promotes parturition. To investigate the regulation of PR expression in cervical stroma, fibroblasts from premenopausal hysterectomy specimens were prepared. Greater than 99% of the cultures were vimentin positive (mesenchymal cell marker) with only occasional cytokeratin-8 positivity (epithelial cell marker) and no evidence of CD31-positive (endothelial cell marker) cells. Cells were immunolabeled with antibodies directed against PRs (PR-A and PR-B), estrogen receptor α (ER-α), and glucocorticoid receptor-α/β (GR-α/β). All cells were uniformly immunopositive for ER-α and GR-α/β but did not express PRs. Incubation of cells with 10−8 mol/L 17β-estradiol induced a time-dependent increase in PR-A and PR-B messenger RNAs (mRNAs) by quantitative real-time polymerase chain reactions and proteins by immunoblotting and immunofluorescence. Incubation of cervical fibroblasts with PR ligands (medroxyprogesterone acetate or Org-2058) downregulated PR-A and PR-B levels. Coincubation of cells with PR ligands plus RU-486, a PR antagonist, partially abrogated agonist-induced receptor downregulation. Dexamethasone, a pure glucocorticoid, had no inhibitory effect on PR expression. These results indicate that progestins and estrogens regulate PR expression in cervical fibroblasts. We postulate that hormonal regulation of PR expression in the cervical stroma may contribute to functional P4 withdrawal in preparation for parturition.
KnissDAIamsJD. Regulation of parturition update. Endocrine and paracrine effectors of term and preterm labor. Clin Perinatol. 1998;25(4):819–836.
2.
MesianoSWelshTN. Steroid hormone control of myometrial contractility and parturition. Sem Cell Dev Biol. 2007;18(3):321–331.
3.
LarsenBHwangJ. Progesterone interactions with the cervix: translational implications for term and preterm birth. Infect Dis Obstet Gynecol. 2011;2011:353297.
CsapoA. Progesterone block. Am J Anat. 1956;98(2):273–291.
6.
MesianoSWangYNorwitzER. Progesterone receptors in the human pregnancy uterus: do they hold the key to birth timing?Reprod Sci. 2011;18(1):6–19.
7.
XuHGonzalezJMOforiEElovitzMA. Preventing cervical ripening: the primary mechanism by which progestational agents prevent preterm birth?Am J Obstet Gynecol. 2008;198(3):314. e311–e318.
8.
PieberDAllportVCHillsFJohnsonMBennettPR. Interactions between progesterone receptor isoforms in myometrial cells in human labour. Mol Hum Reprod. 2001;7(9):875–879.
9.
MadsenGZakarTKuCYSanbornBMSmithRMesianoS. Prostaglandins differentially modulate progesterone receptor-A and -B expression in human myometrial cells: evidence for prostaglandin-induced functional progesterone withdrawal. J Clin Endocrinol Metab. 2004;89(2):1010–1013.
10.
MerlinoAWelshTErdonmezT. Nuclear progesterone receptor expression in the human fetal membranes and decidua at term before and after labor. Reprod Sci. 2009;16(4):357–363.
11.
OnerCSchatzFKizilayG. Progestin-inflammatory cytokine interactions affect matrix metalloproteinase-1 and -3 expression in term decidual cells: implications for treatment of chorioamnionitis-induced preterm delivery. J Clin Endocrinol Metab. 2008;93(1):252–259.
12.
LockwoodCJMurkWKayisliUA. Progestin and thrombin regulate tissue factor expression in human term decidual cells. J Clin Endocrinol Metab. 2009;94(6):2164–2170.
13.
LiXHKishoreAHDaoDZhengWRomanCAWordRA. A novel isoform of microphthalmia-associated transcription factor inhibits IL-8 gene expression in human cervical stromal cells. Mol Endocrinol. 2010;24(8):1512–1528.
14.
HouseMTadesse-TelilaSNorwitzERSocrateSKaplanDL. Inhibitory effect of progesterone on cervical tissue formation in a three-dimensional culture system with human cervical fibroblasts. Biol Reprod. 2014;90(1):18.
15.
ChwaliszK. The use of progesterone antagonists for cervical ripening and as an adjunct to labour and delivery. Hum Reprod. 1994;9(suppl 1
):131–161.
16.
DudleyDJBranchDWEdwinSSMitchellMD. Induction of preterm birth in mice by RU486. Biol Reprod. 1996;55(5):992–995.
17.
GonzalezJMXuHChaiJOforiEElovitzMA. Preterm and term cervical ripening in CD1 Mice (Mus musculus): similar or divergent molecular mechanisms?Biol Reprod. 2009;81(6):1226–1232.
18.
FacchinettiFVaccaroV. Pharmacological use of progesterone and 17-alpha-hydroxyprogesterone caproate in the prevention of preterm delivery. Minerva Ginecologica. 2009;61(5):401–409.
19.
HassanSSRomeroRVidyadhariD. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol. 2011;38(1):18–31.
20.
Conde-AgudeloARomeroRNicolaidesK. Vaginal progesterone vs. cervical cerclage for the prevention of preterm birth in women with a sonographic short cervix, previous preterm birth, and singleton gestation: a systematic review and indirect comparison metaanalysis. Am J Obstet Gynecol. 2013;208(1):42. e41–e42. e18.
21.
DeeksED. 17 alpha-Hydroxyprogesterone caproate (Makena): in the prevention of preterm birth. Paediatric Drugs. 2011;13(5):337–345.
22.
KuonRJShiSQMaulH. Pharmacologic actions of progestins to inhibit cervical ripening and prevent delivery depend on their properties, the route of administration, and the vehicle. Am J Obstet Gynecol. 2010;202(5):455. e451–e459.
23.
RomeroR. Vaginal progesterone to reduce the rate of preterm birth and neonatal morbidity: a solution at last. Womens Health (Lond Engl). 2011;7(5):501–504.
24.
KasidABucksheeKHingoraniVLaumasKR. Interaction of progestins with steroid receptors in human uterus. Biochem J. 1978;176(2):531–539.
25.
HaslamSZShyamalaG. Relative distribution of estrogen and progesterone receptors among the epithelial, adipose, and connective tissue components of the normal mammary gland. Endocrinol. 1981;108(3):825–830.
26.
KurlRNBorthwickNM. Progesterone receptors in human endometrium. Eur J Obstet Gynecol Reprod Biol. 1982;13(5):293–301.
27.
CanoASerraVRiveraJMonmeneuRMarzoC. Expression of estrogen receptors, progesterone receptors, and an estrogen receptor-associated protein in the human cervix during the menstrual cycle and menopause. Fert Steril. 1990;54(6):1058–1064.
28.
LockwoodCJStoccoCMurkWKayisliUAFunaiEFSchatzF. Human labor is associated with reduced decidual cell expression of progesterone, but not glucocorticoid, receptors. J Clin Endocrinol Metab. 2010;95(5):2271–2275.
29.
BurrisTPSoltLAWangY. Nuclear receptors and their selective pharmacologic modulators. Pharmacol Rev. 2013;65(2):710–778.
30.
SnijdersMPde GoeijAFDebets-Te BaertsMJRouschMJKoudstaalJBosmanFT. Immunocytochemical analysis of oestrogen receptors and progesterone receptors in the human uterus throughout the menstrual cycle and after the menopause. J Reprod Fertil. 1992;94(2):363–371.
31.
PressMSpauldingBGroshenS. Comparison of different antibodies for detection of progesterone receptor in breast cancer. Steroids. 2002;67(9):799–813.
32.
LockwoodCJNemersonYGullerS. Progestational regulation of human endometrial stromal cell tissue factor expression during decidualization. J Clin Endocrinol Metab. 1993;76(1):231–236.
33.
BentelJMBirrellSNPickeringMAHoldsDJHorsfallDJTilleyWD. Androgen receptor agonist activity of the synthetic progestin, medroxyprogesterone acetate, in human breast cancer cells. Mol cell Endocrinol. 1999;154(1-2):11–20.
34.
ThomasCPLiuKZVatsHS. Medroxyprogesterone acetate binds the glucocorticoid receptor to stimulate alpha-ENaC and sgk1 expression in renal collecting duct epithelia. Am J Physiol Renal Physiol. 2006;290(2):F306–F312.
35.
BuhimschiIADussablyLBuhimschiCSAhmedAWeinerCP. Physical and biomechanical characteristics of rat cervical ripening are not consistent with increased collagenase activity. Am J Obstet Gynecol. 2004;191(5):1695–1704.
36.
HouseMSocrateS. The cervix as a biomechanical structure. Ultrasound Obstet Gynecol. 2006;28(6):745–749.
37.
MyersKMPaskalevaAPHouseMSocrateS. Mechanical and biochemical properties of human cervical tissue. Acta Biomater. 2008;4(1):104–116.
38.
HouseMKaplanDLSocrateS. Relationships between mechanical properties and extracellular matrix constituents of the cervical stroma during pregnancy. Semin Perinatol. 2009;33(5):300–307.
39.
YellonSMDobynsAEBeckHLKurtzmanJTGarfieldREKirbyMA. Loss of progesterone receptor-mediated actions induce preterm cellular and structural remodeling of the cervix and premature birth. PLoS One. 2013;8(12):e81340.
40.
HaluskaGJCookMJNovyMJ. Inhibition and augmentation of progesterone production during pregnancy: effects on parturition in rhesus monkeys. Am J Obstet Gynecol. 1997;176(3):682–691.
41.
ElliottCLBrennandJECalderAA. The effects of mifepristone on cervical ripening and labor induction in primigravidae. Obstet Gynecol. 1998;92(5):804–809.
42.
StenlundPMEkmanGAedoARBygdemanM. Induction of labor with mifepristone--a randomized, double-blind study versus placebo. Acta Obstet Gynecol Scandinavica. 1999;78(9):793–798.
43.
GiacalonePLDauresJPFaureJMBoulotPHedonBLaffargueF. The effects of mifepristone on uterine sensitivity to oxytocin and on fetal heart rate patterns. Eur J Obstet Gynecol Reprod Biol. 2001;97(1):30–34.
44.
FacchinettiFPaganelliSComitiniGDanteGVolpeA. Cervical length changes during preterm cervical ripening: effects of 17-alpha-hydroxyprogesterone caproate. Am J Obstet Gynecol. 2007;196(5):453 e451–454; discussion 421.
45.
O’BrienJMDefrancoEAAdairCD. Effect of progesterone on cervical shortening in women at risk for preterm birth: secondary analysis from a multinational, randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol. 2009;34(6):653–659.
46.
ChoHAronicaSMKatzenellenbogenBS. Regulation of progesterone receptor gene expression in MCF-7 breast cancer cells: a comparison of the effects of cyclic adenosine 3’,5’-monophosphate, estradiol, insulin-like growth factor-I, and serum factors. Endocrinol. 1994;134(2):658–664.
47.
KrausWLKatzenellenbogenBS. Regulation of progesterone receptor gene expression and growth in the rat uterus: modulation of estrogen actions by progesterone and sex steroid hormone antagonists. Endocrinol. 1993;132(6):2371–2379.
48.
EckertRLKatzenellenbogenBS. Human endometrial cells in primary tissue culture: modulation of the progesterone receptor level by natural and synthetic estrogens in vitro. J Clin Endocrinol Metab. 1981;52(4):699–708.
49.
NardulliAMKatzenellenbogenBS. Progesterone receptor regulation in T47D human breast cancer cells: analysis by density labeling of progesterone receptor synthesis and degradation and their modulation by progestin. Endocrinol. 1988;122(4):1532–1540.
50.
LangeCAShenTHorwitzKB. Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome. Proc Natl Acad Sci U S A. 2000;97(3):1032–1037.
51.
IsmailANawazZ. Nuclear hormone receptor degradation and gene transcription: an update. IUBMB Life. 2005;57(7):483–490.
52.
PerissiVRosenfeldMG. Controlling nuclear receptors: the circular logic of cofactor cycles. Nat Rev Mol Cell Biol. 2005;6(7):542–554.
53.
TsengLZhuHH. Regulation of progesterone receptor messenger ribonucleic acid by progestin in human endometrial stromal cells. Biol Reprod. 1997;57(6):1360–1366.
54.
TangMMazellaJGaoJTsengL. Progesterone receptor activates its promoter activity in human endometrial stromal cells. Mol Cell Endocrinol. 2002;192(1-2):45–53.
FukuyamaATanakaKKakizakiI. Anti-inflammatory effect of proteoglycan and progesterone on human uterine cervical fibroblasts. Life Sci. 2012;90(13-14):484–488.
57.
KimMGShimJYPakJH. Progesterone modulates the expression of interleukin-6 in cultured term human uterine cervical fibroblasts. Am J Reprod Immunol. 2012;67(5):369–375.
58.
LippmanMBolanGHuffK. The effects of glucocorticoids and progesterone on hormone-responsive human breast cancer in long-term tissue culture. Cancer Res. 1976;36(12):4602–4609.
59.
AttardiBJZeleznikASimhanHChiaoJPMattisonDRCaritisSN. Comparison of progesterone and glucocorticoid receptor binding and stimulation of gene expression by progesterone, 17-alpha hydroxyprogesterone caproate, and related progestins. Am J Obstet Gynecol. 2007;197(6):599. e591–e597.
60.
LeiKChenLGeorgiouEX. Progesterone acts via the nuclear glucocorticoid receptor to suppress IL-1beta-induced COX-2 expression in human term myometrial cells. PLoS One. 2012;7(11):e50167.
61.
EickGNThorntonJW. Evolution of steroid receptors from an estrogen-sensitive ancestral receptor. Mol Cell Endocrinol. 2011;334(1-2):31–38.
62.
EickGNColucciJKHarmsMJOrtlundEAThorntonJW. Evolution of minimal specificity and promiscuity in steroid hormone receptors. PLoS Genet. 2012;8(11):e1003072.
63.
LuNZWardellSEBurnsteinKL. International Union of Pharmacology. LXV. The pharmacology and classification of the nuclear receptor superfamily: glucocorticoid, mineralocorticoid, progesterone, and androgen receptors. Pharmacol Rev. 2006;58(4):782–797.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
